Published in Genes (Basel) on May 17, 2017
Hallmarks of cancer: the next generation. Cell (2011) 140.01
The hallmarks of cancer. Cell (2000) 113.05
Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature (2008) 75.40
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med (2005) 74.55
The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (2007) 49.11
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell (2010) 39.09
The serial cultivation of human diploid cell strains. Exp Cell Res (1961) 25.11
Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell (1985) 24.17
Malignant gliomas in adults. N Engl J Med (2008) 20.54
Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell (2010) 16.12
Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev (2005) 15.19
Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell (2011) 11.44
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature (2012) 10.99
Histone H3.1 and H3.3 complexes mediate nucleosome assembly pathways dependent or independent of DNA synthesis. Cell (2004) 10.16
CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol (2012) 8.16
Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med (1997) 6.55
Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science (2007) 6.33
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol (2016) 6.24
Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J (1995) 6.03
How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol (2007) 5.80
Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer (2011) 5.12
Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II. Nat Cell Biol (2007) 4.84
Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med (2006) 4.61
Altered telomeres in tumors with ATRX and DAXX mutations. Science (2011) 4.60
DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol (2006) 4.38
Alternative lengthening of telomeres: models, mechanisms and implications. Nat Rev Genet (2010) 4.26
The epigenetic regulation of mammalian telomeres. Nat Rev Genet (2007) 3.82
Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell (2012) 3.65
ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells. Genome Res (2010) 3.46
Beginning to understand the end of the chromosome. Cell (2004) 3.46
Human telomerase and its regulation. Microbiol Mol Biol Rev (2002) 3.11
Nuclear-receptor-mediated telomere insertion leads to genome instability in ALT cancers. Cell (2015) 2.79
Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat Rev Cancer (2011) 2.66
Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genet (2012) 2.63
Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma. Nat Med (2014) 2.53
A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases. Nat Struct Mol Biol (2008) 2.43
Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres. Nat Genet (2007) 2.37
Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell (2013) 2.28
Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme. Lancet (2003) 2.26
Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors. Science (2015) 2.24
Current concepts and management of glioblastoma. Ann Neurol (2011) 2.23
Hayflick, his limit, and cellular ageing. Nat Rev Mol Cell Biol (2000) 2.15
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat Med (2015) 2.07
The non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomerase. Nucleic Acids Res (2010) 2.05
Telomere lengthening early in development. Nat Cell Biol (2007) 2.02
A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clin Cancer Res (2005) 1.95
The first molecular details of ALT in human tumor cells. Hum Mol Genet (2005) 1.93
Natural and pharmacological regulation of telomerase. Nucleic Acids Res (2002) 1.92
Molecular dissection of telomeric repeat-containing RNA biogenesis unveils the presence of distinct and multiple regulatory pathways. Mol Cell Biol (2010) 1.89
Hypomethylation of subtelomeric regions in ICF syndrome is associated with abnormally short telomeres and enhanced transcription from telomeric regions. Hum Mol Genet (2008) 1.67
CpG-island promoters drive transcription of human telomeres. RNA (2009) 1.66
Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers. FEBS Lett (2010) 1.64
Rapid induction of alternative lengthening of telomeres by depletion of the histone chaperone ASF1. Nat Struct Mol Biol (2014) 1.62
The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry. J Neurooncol (2009) 1.58
Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription. Nucleic Acids Res (2009) 1.55
Break-induced telomere synthesis underlies alternative telomere maintenance. Nature (2016) 1.55
Telomere length regulates TERRA levels through increased trimethylation of telomeric H3K9 and HP1α. Nat Struct Mol Biol (2012) 1.52
Telomerase: central regulator of all of the hallmarks of cancer. Trends Biochem Sci (2013) 1.46
Telomere maintenance mechanisms and cellular immortalization. Curr Opin Genet Dev (1999) 1.43
Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors. Gastroenterology (2013) 1.39
Mobile DNA elements in the generation of diversity and complexity in the brain. Nat Rev Neurosci (2014) 1.35
Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survival. J Neuropathol Exp Neurol (2010) 1.32
Low values of 5-hydroxymethylcytosine (5hmC), the "sixth base," are associated with anaplasia in human brain tumors. Int J Cancer (2012) 1.30
Telomerase redefined: integrated regulation of hTR and hTERT for telomere maintenance and telomerase activity. Biochimie (2007) 1.26
Genetic and epigenetic modulation of telomerase activity in development and disease. Gene (2004) 1.25
A functional polymorphism at microRNA-629-binding site in the 3'-untranslated region of NBS1 gene confers an increased risk of lung cancer in Southern and Eastern Chinese population. Carcinogenesis (2011) 1.24
Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters. Cancer Res (2005) 1.23
Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev (2014) 1.22
A role for CTCF and cohesin in subtelomere chromatin organization, TERRA transcription, and telomere end protection. EMBO J (2012) 1.21
Role of Tet proteins in enhancer activity and telomere elongation. Genes Dev (2014) 1.19
Immortalized cells with no detectable telomerase activity. A review. Biochemistry (Mosc) (1997) 1.11
Alternative lengthening of telomeres in human glioma stem cells. Stem Cells (2011) 1.10
Replicative senescence: considerations relating to the stability of heterochromatin domains. Exp Gerontol (1996) 1.08
Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene. Protein Cell (2010) 1.07
Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells. Oncogene (2009) 1.07
L1 retrotransposons and somatic mosaicism in the brain. Annu Rev Genet (2014) 1.05
Alternative Lengthening of Telomeres is characterized by reduced compaction of telomeric chromatin. Nucleic Acids Res (2014) 1.05
Alternative lengthening of telomeres in normal mammalian somatic cells. Genes Dev (2013) 1.04
Role of Telomeres and Telomerase in Aging and Cancer. Cancer Discov (2016) 1.03
Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX. Nat Commun (2015) 1.03
Variant repeats are interspersed throughout the telomeres and recruit nuclear receptors in ALT cells. J Cell Biol (2012) 1.02
Alternative lengthening of telomeres pathway: recombination-mediated telomere maintenance mechanism in human cells. J Biochem (2010) 1.02
Cancer. Cancer and telomeres--an ALTernative to telomerase. Science (2012) 1.00
Alternative lengthening of telomeres: remodeling the telomere architecture. Front Oncol (2013) 1.00
The WHO Classification of Tumours of the Central Nervous System, 4th edition. Arch Pathol Lab Med (2008) 0.98
Epigenetic control of telomerase and modes of telomere maintenance in aging and abnormal systems. Front Biosci (2005) 0.98
Non-coding RNA in neural function, disease, and aging. Front Genet (2015) 0.97
Complex interactions between the DNA-damage response and mammalian telomeres. Nat Struct Mol Biol (2015) 0.97
The origins of glioma: E Pluribus Unum? Glia (2011) 0.97
Advances in the molecular genetics of gliomas - implications for classification and therapy. Nat Rev Clin Oncol (2016) 0.96
ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma. Sci Transl Med (2016) 0.95
Lack of telomerase RNA gene hTERC expression in alternative lengthening of telomeres cells is associated with methylation of the hTERC promoter. Cancer Res (2001) 0.94
MicroRNA therapeutics in preclinical cancer models. Lancet Oncol (2011) 0.93
NuRD-ZNF827 recruitment to telomeres creates a molecular scaffold for homologous recombination. Nat Struct Mol Biol (2014) 0.93
Molecular mechanisms of activity and derepression of alternative lengthening of telomeres. Nat Struct Mol Biol (2015) 0.92
A three-state model for the regulation of telomerase by TERRA and hnRNPA1. Nucleic Acids Res (2013) 0.92
TERRA and the state of the telomere. Nat Struct Mol Biol (2015) 0.91
Understanding TERT Promoter Mutations: A Common Path to Immortality. Mol Cancer Res (2016) 0.90
Expression of telomeres in astrocytoma WHO grade 2 to 4: TERRA level correlates with telomere length, telomerase activity, and advanced clinical grade. Transl Oncol (2012) 0.89
HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation. Oncotarget (2015) 0.88
Telomere Transcripts Target Telomerase in Human Cancer Cells. Genes (Basel) (2016) 0.75